ODI Pharma AB (publ) (NGM: ODI)

Sweden flag Sweden · Delayed Price · Currency is SEK
3.780
+0.020 (0.53%)
At close: Jan 24, 2025
-25.88%
Market Cap 54.18M
Revenue (ttm) 22.06M
Net Income (ttm) 330.32K
Shares Out 15.22M
EPS (ttm) 0.02
PE Ratio 164.03
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,487
Average Volume 7,574
Open 3.660
Previous Close 3.760
Day's Range 3.660 - 3.780
52-Week Range 2.080 - 8.150
Beta 0.66
RSI 52.77
Earnings Date Feb 21, 2025

About ODI Pharma AB

ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products under the Kandol brand. The company was founded in 2018 and is based in Stockholm, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2018
Employees 1
Stock Exchange Nordic Growth Market
Ticker Symbol ODI
Full Company Profile

Financial Performance

In 2024, ODI Pharma AB's revenue was 22.29 million, an increase of 15880.34% compared to the previous year's 139,457. Losses were -568,059, -91.77% less than in 2023.

Financial Statements

News

There is no news available yet.